Conjugated polymer nanoparticles (CPN) are fluorescence emitting entities, which find applications in bioimaging, research & development, and photo optics. CPNs comprise light emitting polymers at the core and are encapsulated with hydrophilic polymer coating. Fluorescent imaging allows real time structural and functional study and visualization of cellular and molecular entities, without interfering the biological processes. Moreover, these imaging and visualization techniques are highly sensitive and tunable as per requirements compared to conventional imaging techniques. These factors have lead to high expectation and preference for fluorescent imaging and visualization techniques. Fluorescent organic dye probes have been in use in bioimaging and R&D applications; however, these pose concerns such as low stability and photo bleaching. CPNs, on the other hand, offer high photoluminescence quantum yield often termed as brightness, better stability, rapid emission rate, and non-blinking behavior.
Conjugated polymer nanoparticles are available in various colors in the range of 450 nm to 680 nm. This wavelength augments deep penetration of light and high sensitivity. CPNs offer better luminance and bio-compatibility. These can be easily conjugated with biological or molecular entities such as antibodies, oligosaccharides, and peptides, which can aid in targeted imaging and visualization of cellular and molecular entities. Several suppliers are offering pre-conjugated CPNs with biological molecules such as antibodies. For instance, Stream Bio Ltd. has introduced streptavidin conjugated CPNs. These features have expanded the usage of CPNs in applications such as flow cytometry, cell imaging, immunohistochemistry, immunocytometry, ELISA, and Western Blotting. Certain CPNs are also available with iron oxide molecules at the core which helps visualization in magnetic resonance imaging (MRI). It further assists in manipulation and purification using magnets. However, adoption of conjugated polymer nanoparticles is low, owing to small number of suppliers, cumbersome production process, and lack of infrastructure. Increase in R&D expenditure for scientific studies by public and private sectors and rise in access to these advanced technologies are anticipated to fuel the uptake of CPNs in the near future.
The global conjugated polymer nanoparticles market can be segmented based on product, conjugate, application, end-user, and region. In terms of product, the conjugated polymer nanoparticles market can be bifurcated into pre-conjugated and customized CPNs. Owing to technical difficulties in conjugating the CPNs at end-user site, suppliers are likely to offer pre-conjugated CPNs in the near future. Based on conjugate, the global conjugated polymer nanoparticles market can be classified into antibody, streptavidin, biotin, protein A, and others. In terms of application, the conjugated polymer nanoparticles market can be categorized into bioimaging, in vitro diagnostics, and life sciences R&D. Based on end-user, the conjugated polymer nanoparticles market can be divided into hospitals, diagnostic centers, academic research institutes, pharmaceutical & biotechnology industries, and others.
In terms of region, the global conjugated polymer nanoparticles market can be segmented into North America, Europe, Asia Pacific, and Rest of the World. High adoption of technologically advanced clinical research tools and high R&D expenditure by the public and private sectors in the U.S. are anticipated to contribute to the growth of the conjugated polymer nanoparticles market in North America. Europe is projected to account for significant share of the global market owing to well-established health care infrastructure and large base of pharmaceutical and biotechnology industries. Increase in public and private sector investment in developing health care and R&D infrastructure in emerging markets such as China and India is expected to augment the market in Asia Pacific during the forecast period.
There are limited number of suppliers of conjugated polymer nanoparticles in the global market. Moreover, several public sector universities and research institutes invest in the development of new CPNs. Key players in the global conjugated polymer nanoparticles market include Stream Bio Ltd., Spherotech, Inc., and Bio Trend.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.